Lataa...
Effect of rpoB Mutations Conferring Rifampin Resistance on Fitness of Mycobacterium tuberculosis
Rifampin is a major drug used in the treatment of tuberculosis infections, and increasing rifampin resistance represents a worldwide clinical problem. Resistance to rifampin is caused by mutations in the rpoB gene, encoding the β-subunit of RNA polymerase. We examined the effect of three different r...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology
2004
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC375340/ https://ncbi.nlm.nih.gov/pubmed/15047531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.4.1289-1294.2004 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|